

1,402,080 filings since 2004 · latest accepted Nov 4, 2026, 8:46 AM ET
Priority items usually mark a change in credit, accounting integrity, control or listing status: 1.02 Agreement terminated, 1.03 Bankruptcy, 1.05 Cybersecurity incident, 2.04 Debt acceleration, 2.05 Restructuring costs, 2.06 Impairment, 3.01 Delisting notice, 4.01 Auditor change, 4.02 Non-reliance (restatement), 5.01 Change in control.
| Filed | Company | Items | Filing |
|---|---|---|---|
Sep 16, 2026 accepted 4:50 PM ET | ERNAErnexa Therapeutics Inc. | 5.02Officer / director change | DocumentSEC ↗ |
Jun 26, 2026 accepted 4:30 PM ET | ERNAErnexa Therapeutics Inc. | Officer / director change |
Source: SEC EDGAR. Same-day filings appear within minutes and are re-checked against SEC's nightly index. Tickers are current listings, so a company's older filings show its ticker today.
| DocumentSEC ↗ |
Jan 10, 2025 accepted 4:15 PM ET | ERNAErnexa Therapeutics Inc. | 3.01Delisting notice5.02Officer / director change | DocumentSEC ↗ |
Feb 16, 2024 accepted 7:30 AM ET | ERNAErnexa Therapeutics Inc. | 5.02Officer / director change | DocumentSEC ↗ |
Dec 20, 2023 accepted 4:20 PM ET | ERNAErnexa Therapeutics Inc. | 1.01Material agreement2.03New debt obligation3.02Unregistered equity sale5.02Officer / director change8.01Other events | DocumentSEC ↗ |
Nov 1, 2023 accepted 8:34 AM ET | ERNAErnexa Therapeutics Inc. | 5.02Officer / director change | DocumentSEC ↗ |
Oct 5, 2023 accepted 4:30 PM ET | ERNAErnexa Therapeutics Inc. | 3.01Delisting notice5.02Officer / director change8.01Other events | DocumentSEC ↗ |
Sep 26, 2023 accepted 4:30 PM ET | ERNAErnexa Therapeutics Inc. | 8-K/A 5.02Officer / director change | DocumentSEC ↗ |
Aug 31, 2023 accepted 4:15 PM ET | ERNAErnexa Therapeutics Inc. | 5.02Officer / director change | DocumentSEC ↗ |
Aug 10, 2023 accepted 4:10 PM ET | ERNAErnexa Therapeutics Inc. | 3.01Delisting notice5.02Officer / director change | DocumentSEC ↗ |
Jul 11, 2023 accepted 4:15 PM ET | ERNAErnexa Therapeutics Inc. | 5.02Officer / director change | DocumentSEC ↗ |
May 5, 2023 accepted 6:30 AM ET | ERNAErnexa Therapeutics Inc. | 5.02Officer / director change | DocumentSEC ↗ |
Jan 26, 2023 accepted 4:31 PM ET | ERNAErnexa Therapeutics Inc. | 5.02Officer / director change | DocumentSEC ↗ |
Jan 4, 2023 accepted 8:35 AM ET | ERNAErnexa Therapeutics Inc. | 3.01Delisting notice5.02Officer / director change | DocumentSEC ↗ |
Sep 1, 2022 accepted 4:45 PM ET | ERNAErnexa Therapeutics Inc. | 8-K/A 5.02Officer / director change | DocumentSEC ↗ |
Aug 5, 2022 accepted 4:32 PM ET | ERNAErnexa Therapeutics Inc. | 5.02Officer / director change | DocumentSEC ↗ |
Jul 27, 2022 accepted 4:30 PM ET | ERNAErnexa Therapeutics Inc. | 5.02Officer / director change | DocumentSEC ↗ |
Jun 7, 2022 accepted 4:45 PM ET | ERNAErnexa Therapeutics Inc. | 5.02Officer / director change | DocumentSEC ↗ |
May 31, 2022 accepted 7:30 AM ET | ERNAErnexa Therapeutics Inc. | 5.02Officer / director change7.01Reg FD disclosure8.01Other events | DocumentSEC ↗ |
Jan 20, 2022 accepted 7:40 AM ET | ERNAErnexa Therapeutics Inc. | 5.02Officer / director change | DocumentSEC ↗ |
Dec 21, 2021 accepted 4:30 PM ET | ERNAErnexa Therapeutics Inc. | 5.02Officer / director change | DocumentSEC ↗ |
Sep 23, 2021 accepted 4:30 PM ET | ERNAErnexa Therapeutics Inc. | 4.01Auditor change5.02Officer / director change5.03Bylaws / fiscal year7.01Reg FD disclosure | DocumentSEC ↗ |
Jul 19, 2021 accepted 5:29 PM ET | ERNAErnexa Therapeutics Inc. | 5.02Officer / director change | DocumentSEC ↗ |
Jun 21, 2021 accepted 5:00 PM ET | ERNAErnexa Therapeutics Inc. | 5.02Officer / director change | DocumentSEC ↗ |
Jun 10, 2021 accepted 5:20 PM ET | ERNAErnexa Therapeutics Inc. | 5.02Officer / director change | DocumentSEC ↗ |
May 26, 2021 accepted 5:20 PM ET | ERNAErnexa Therapeutics Inc. | 1.01Material agreement3.02Unregistered equity sale5.02Officer / director change | DocumentSEC ↗ |
May 11, 2021 accepted 5:25 PM ET | ERNAErnexa Therapeutics Inc. | 5.02Officer / director change8.01Other events | DocumentSEC ↗ |
Apr 16, 2021 accepted 5:20 PM ET | ERNAErnexa Therapeutics Inc. | 5.02Officer / director change | DocumentSEC ↗ |
Apr 7, 2021 accepted 5:18 PM ET | ERNAErnexa Therapeutics Inc. | 1.01Material agreement5.02Officer / director change7.01Reg FD disclosure | DocumentSEC ↗ |
Mar 31, 2021 accepted 5:18 PM ET | ERNAErnexa Therapeutics Inc. | 2.01Acquisition / disposition3.03Holder rights modified5.01Change in control5.02Officer / director change5.03Bylaws / fiscal year8.01Other events | DocumentSEC ↗ |
Sep 18, 2020 accepted 5:19 PM ET | ERNAErnexa Therapeutics Inc. | 1.01Material agreement2.03New debt obligation5.02Officer / director change7.01Reg FD disclosure | DocumentSEC ↗ |
Jun 2, 2020 accepted 4:30 PM ET | ERNAErnexa Therapeutics Inc. | 5.02Officer / director change | DocumentSEC ↗ |
Apr 3, 2020 accepted 4:10 PM ET | ERNAErnexa Therapeutics Inc. | 5.02Officer / director change | DocumentSEC ↗ |
Mar 30, 2020 accepted 4:15 PM ET | ERNAErnexa Therapeutics Inc. | 3.01Delisting notice5.02Officer / director change8.01Other events | DocumentSEC ↗ |
Jan 15, 2020 accepted 4:15 PM ET | ERNAErnexa Therapeutics Inc. | 1.01Material agreement5.02Officer / director change7.01Reg FD disclosure | DocumentSEC ↗ |
Nov 26, 2019 accepted 8:35 AM ET | ERNAErnexa Therapeutics Inc. | 5.02Officer / director change7.01Reg FD disclosure | DocumentSEC ↗ |
Sep 17, 2019 accepted 4:40 PM ET | ERNAErnexa Therapeutics Inc. | 5.02Officer / director change | DocumentSEC ↗ |
Sep 3, 2019 accepted 6:35 AM ET | ERNAErnexa Therapeutics Inc. | 5.02Officer / director change7.01Reg FD disclosure | DocumentSEC ↗ |
Mar 20, 2019 accepted 4:15 PM ET | ERNAErnexa Therapeutics Inc. | 2.02Earnings release5.02Officer / director change | DocumentSEC ↗ |
Mar 22, 2018 accepted 5:00 PM ET | ERNAErnexa Therapeutics Inc. | 5.02Officer / director change | DocumentSEC ↗ |
Oct 25, 2017 accepted 4:30 PM ET | ERNAErnexa Therapeutics Inc. | 5.02Officer / director change | DocumentSEC ↗ |
Jul 10, 2017 accepted 8:36 AM ET | ERNAErnexa Therapeutics Inc. | 5.02Officer / director change | DocumentSEC ↗ |
Mar 14, 2017 accepted 6:41 PM ET | ERNAErnexa Therapeutics Inc. | 5.02Officer / director change | DocumentSEC ↗ |
Feb 29, 2016 accepted 4:41 PM ET | ERNAErnexa Therapeutics Inc. | 5.02Officer / director change | DocumentSEC ↗ |
Feb 2, 2016 accepted 7:15 AM ET | ERNAErnexa Therapeutics Inc. | 3.01Delisting notice5.02Officer / director change8.01Other events | DocumentSEC ↗ |
Jan 22, 2016 accepted 4:30 PM ET | ERNAErnexa Therapeutics Inc. | 5.02Officer / director change | DocumentSEC ↗ |
May 14, 2015 accepted 4:26 PM ET | ERNAErnexa Therapeutics Inc. | 5.02Officer / director change | DocumentSEC ↗ |
Apr 20, 2015 accepted 4:45 PM ET | ERNAErnexa Therapeutics Inc. | 5.02Officer / director change | DocumentSEC ↗ |
Apr 16, 2015 accepted 8:40 AM ET | ERNAErnexa Therapeutics Inc. | 1.01Material agreement2.03New debt obligation5.02Officer / director change | DocumentSEC ↗ |
Dec 19, 2014 accepted 8:35 AM ET | ERNAErnexa Therapeutics Inc. | 5.02Officer / director change | DocumentSEC ↗ |